Table 2.
Property | Parecoxib (mean) n = 14 | Indomethacin (mean) n = 14 | Placebo (mean) n = 14 | Mean difference placebo versus parecoxib (post hoc) | Mean difference placebo versus indomethacin (post hoc) |
---|---|---|---|---|---|
Moment (ratio) | 0.11 (SD 0.16) | 0.10 (SD 0.09) | 0.29 (SD 0.22) | 0.18 (CI 0.019–0.334) | 0.18 (CI 0.026–0.340) |
p = 0.02 | p = 0.02 | ||||
Total energy (ratio) | 0.12 (SD 0.18) | 0.10 (SD 0.09) | 0.18 (SD 0.16) | 0.05 (CI −0.089–0.195) | 0.08 (CI −0.063–0.221) |
p = 0.64 | p = 0.37 | ||||
Stiffness (ratio) | 0.12 (SD 0.22) | 0.14 (SD 0.16) | 0.62 (SD 0.66) | 0.51 (CI 0.108–0.904) | 0.49 (CI 0.088–0.884) |
p = 0.01 | p = 0.01 | ||||
Deflection (ratio) | 1.61 (SD 0.74) | 1.68 (SD 0.91) | 1.04 (SD 0.53) | −0.57 (CI −1.286–0.147) | −0.64 (CI −1.360–0.073) |
p = 0.14 | p = 0.09 |
Groups compared using ANOVA and Scheffe’s post hoc test. Level of significance set at p < 0.05. Results are given as mean values, one standard deviation (SD) and 95% confidence interval of mean difference (CI).